Meanwhile, in Europe ...

I cannot find any health care voices against transgenderism in Europe.  Are there none?  Are they silenced, by peers or activists or a Google filter?  Even the famous Swedish study, a thirty-year cohort study published in 2011, which cited higher mortality (suicide; also, cardiovascular disease and cancers - both of which may be increased by the hormone regimens, although this remains to be defined) and morbidity (increased suicide attempts, increased inpatient psychiatric care for issues other than transgenderism, increased male-pattern violence among male-to-female individuals), was careful in its conclusion to not advocate against transgender hormones and surgery:

"This study found substantially higher rates of overall mortality, death from cardiovascular disease and suicide, suicide attempts, and psychiatric hospitalisations in sex-reassigned transsexual individuals compared to a healthy control population. This highlights that post surgical transsexuals are a risk group that need long-term psychiatric and somatic follow-up. Even though surgery and hormonal therapy alleviates gender dysphoria, it is apparently not sufficient to remedy the high rates of morbidity and mortality found among transsexual persons. Improved care for the transsexual group after the sex reassignment should therefore be considered."

Note the cautiously embedded recommendation that the 'improved care' transgendered patients need is not more of the care currently offered - hormones and surgery - but psychiatric.

I recommend we start with improved psychiatric care for individuals who identify as transgender, and then see if the next steps deemed appropriate are hormones and surgery.